Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL5479745 | 1.00 | ALDH1A1 (0.55) | — | |
| Phosphoric Acid SCHEMBL10821982 | 0.96 | ALDH1A1 (0.50) | — | |
| Phosphoric Acid SCHEMBL28973385 | 0.96 | ALDH1A1 (0.50) | — | |
| Phosphoric Acid SCHEMBL29083036 | 0.96 | ALDH1A1 (0.50) | — | |
| Phosphoric Acid SCHEMBL28357709 | 0.91 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL15540730 | 0.86 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL5901916 | 0.86 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL571124 | 0.86 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL8435606 | 0.84 | — | — | |
| Phosphoric Acid SCHEMBL15911057 | 0.84 | CA2 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240201140-A1 | METHOD FOR THE ANALYSIS OF RELATED SUBSTANCES IN CYCLOSPORINE A PREPARATION, AND USE THEREOF | ZHAOKE (GUANGZHOU) OPHTHALMOLOGY PHARMACEUTICAL LIMITED (CN) | 2024-06-20 | — | — | US | claimed |
| CN-115266996-B | Analysis method and application of related substances in cyclosporine A preparation | 兆科（广州）眼科药物有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-115266996-A | Analysis method and application of related substances in cyclosporin A preparation | 兆科（广州）眼科药物有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-109374760-A | A kind of method of micro-extraction-Capillary Electrophoresis combination measurement colony induction signaling molecule | 青岛科技大学 | 2019-02-22 | — | — | CN | claimed |
| US-20190007998-A1 | Rare-Earth Doped Semiconductor Infrared Radiation Thick-Film Electronic Paste and Preparation Method Therefor | Corehelm Electronic Material Co., Ltd. (CN) | 2019-01-03 | — | — | US | claimed |
| CN-108913729-A | A kind of enzyme reducing preparation method of Nebivolol Intermediates | 浙江车头制药股份有限公司 | 2018-11-30 | — | — | CN | claimed |
| CN-105816432-A | Freeze-drying ropivacaine hydrochloride composition for injection and quality control method thereof | 成都天台山制药有限公司 | 2016-08-03 | — | — | CN | claimed |
| EP-1458616-B1 | CHEMICAL CONTAINER FOR HIGH-PURE CHEMICALS | HONEYWELL SPECIALTY CHEMICALS (DE) | 2006-07-26 | — | — | EP | claimed |
| US-20060037931-A1 | Chemical container for high-pure chemicals | HAHN HANS-ULRICH | 2006-02-23 | — | — | US | claimed |
| EP-1458616-A1 | CHEMICAL CONTAINER FOR HIGH-PURE CHEMICALS | Honeywell Specialty Chemicals Seelze GmbH (DE) | 2004-09-22 | — | — | EP | claimed |
| WO-2003045790-A1 | CHEMICAL CONTAINER FOR HIGH-PURE CHEMICALS | HONEYWELL SPECIALTY CHEMICALS SEELZE GMBH (DE) | 2003-06-05 | — | — | WO | claimed |
| CN-119775280-A | Repentinib phosphate intermediate and preparation method thereof | 安徽联创生物医药股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-20240201140-A1 | METHOD FOR THE ANALYSIS OF RELATED SUBSTANCES IN CYCLOSPORINE A PREPARATION, AND USE THEREOF | ZHAOKE (GUANGZHOU) OPHTHALMOLOGY PHARMACEUTICAL LIMITED (CN) | 2024-06-20 | — | — | US | disclosed |
| CN-115266996-B | Analysis method and application of related substances in cyclosporine A preparation | 兆科（广州）眼科药物有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-116601245-A | Curable coating composition and article | 信越化学工业株式会社 | 2023-08-15 | — | — | CN | disclosed |
| EP-0386614-A1 | Cell growth enhancers and/or antibody production stimulators comprising chemically modified hydrophilic polyurea-urethane prepolymers and polymers | W.R. Grace & Co.-Conn. (US) | 1990-09-12 | — | — | EP | disclosed |
| US-4940737-A | Biocompatible polyurethane three-dimensional hydrogels or foams | W. R. GRACE & CO.-CONN (US) | 1990-07-10 | — | — | US | disclosed |
| US-4929706-A | POLYOXYETHYLENE PREPOLYMERS | W. R. GRACE & CO.-CONN. (US) | 1990-05-29 | — | — | US | disclosed |
| EP-0367362-A2 | Chemically modified hydrophilic prepolymers and polymers | W.R. Grace & Co.-Conn. (US) | 1990-05-09 | — | — | EP | disclosed |
| US-3903272-A | Microbiocide process and composition effective against sulfate reducing bacteria waterflooding operations | NALCO CHEMICAL CO | 1975-09-02 | — | — | US | disclosed |